Navigate Fool.com
Will CPRX beat
the market?
Community Rating: 3 Stars: Appealing

2.06 0.03 (1.48%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $2.04
Previous Close $2.03
Daily Range $1.97 - $2.09
52-Week Range $0.48 - $3.65
Market Cap $134.9M
P/E Ratio -7.63
Dividend (Yield) $0.00 (0.0%)
Volume 269,093
Average Daily Volume 1,160,766
Current FY EPS -$0.32

How do you think CPRX
will perform against the market?

Top CPRX Bull/Bear Pitches


There are no pitches that meet the Top Bull criteria. Explain

If this upsets you, start recommending pitches here!


zzlangerhans (< 20)
Submitted September 13, 2011

Catalyst is a cash-poor outfit tackling the rather crowded field of therapies for substance addiction. I gave them a pass the first time I reviewed them, but three months later I see the kitty down to … More

0 Replies Reply Report this Post

News & Commentary Rss Feed

This Week in Biotech: Part 2

A look at the biggest stories this week in biotech and what they mean for investors.

Sector Update: Healthcare Shares Flat Pre-Market; Catalyst Pharmaceutical Partners Rises 14% on Join

Sector Update: Healthcare Shares Flat Pre-Market; Catalyst Pharmaceutical Partners Rises 14% on Joint Study of Firdapse Tablets

Sector Update: Healthcare

US Stocks Seen Higher on Expected Yellen Support; Economic Data, Fed Minutes in Focus

US Stocks Seen Extending Gains on Fed Support

Catalyst Stock Plunge: Ugly In Orphan Drug Land

Healthcare Stocks Adding to Early Gains; Catalyst Pharma Surging Following Insider Buying

Sector Update: Healthcare

Tuesday Closing Bell: Markets Sink on Syria Worries

Stocks Drop Amid Likely Syria Intervention And Domestic Debt Ceiling Fight

US Futures Fall as Prospects for Syria Intervention Increase

See More CPRX News...






A development-stage pharmaceutical company focused on the acquisition, development and commercialization of prescription drugs for the treatment of drug addiction. Website: http://www.catalystpharma.com/

Featured Broker Partners

Learn more about our new Fool ticker page!

Take a Tour
no thanks